Under construction – not a live service
Sign in
Taking people in HungaryNo phase

Studying mitochondria in women with PCOS, insulin resistance and infertility

Observes mitochondrial changes in women aged 20 to 45 with polycystic ovary syndrome.

Plain-language title generated from the registry record
Registry title: Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort

Key facts

Where
Budapest, HungarySee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 20 to 45 with polycystic ovary syndrome (PCOS), insulin resistance, infertility or a mitochondrial problem, and for healthy women as a comparison group.

Age
20 to 45 years
Sex
Women only
Disease stage
PCOS or insulin resistance together with other body-wide signs and mitochondrial dysfunction; or infertility together with the same; or a known mitochondrial dysfunction with PCOS and/or insulin resistance.

Main reasons for not taking part

  • Poor cooperation
  • Refusing to take part in the study
  • A serious medical condition that would make taking part highly risky

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 45 years old?

Source: NCT06167135, who can take part

Where in Hungary

  • Semmelweis UniversityBudapest, HungaryContact: Vera Várhegyi, MDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Semmelweis University
Trial code
NCT06167135
Record updated
18 December 2023
Original description
Enrolling of 150 female patients of fertile age diagnosed with PCOS, insulin resistance, infertility, or mitochondrial disease, and the same number of age- and sex-matched controls are planned.Read full original descriptionShow less

Polycystic Ovary Syndrome, Insulin Resistance, Infertility, Obesity, and the Associated Mitochondrial Dysfunction With These Disorders in Hungarian Patients

Enrolling of 150 female patients of fertile age diagnosed with PCOS, insulin resistance, infertility, or mitochondrial disease, and the same number of age- and sex-matched controls are planned.

During the research biomarkers already with mitochondrial dysfunction in the scientific literature and common mtDNA abnormalities (deletions, point mutations, copy number changes, etc.) are examined.

Inclusion: Presence of polycystic ovary syndrome (PCOS) or insulin resistance (IR) associated with other multisystemic phenotypes, mitochondrial dysfunction; history of infertility associated with other multisystemic phenotypes, mitochondrial dysfunction; a known history of mitochondrial dysfunction and PCOS and/or IR; general health is good and there is no serious general medical condition that would prevent participation would make participation highly risky.

Exclusion: poor cooperation; refusal to participate in the study.

ClinicalTrials.gov NCT06167135